Korea University Anam Hospital

Seoul, Gyeonggi-do 02841

0 studies enrolling now · 2 studies all time

What they study most

ALK-positive Advanced NSCLC, Advanced Non-Small Cell Lung Cancer

Studies at this site

• A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) — Running, not enrolling
• A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed